Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.PPD, a contract research organization, has announced that it plans to expand its global central lab services into Singapore in response to growing client demand in Southeast Asia.
Subscribe to our email newsletter
The lab is expected to begin operations in mid-2009 and will provide biopharmaceutical clients with a comprehensive range of highly customized lab services.
According to the company, the equipment in Singapore is identical to platforms located at PPD’s global central labs in Brussels, Belgium; Highland Heights, Kentucky; and Beijing, China. Assays will be extensively cross validated among PPD’s locations to produce combinable data.
PPD said that its Singapore lab will interface directly with ConneXion, the company’s global computer system, to ensure consistent management and real-time reporting. Minutes thereafter, clients can view and analyze their results with those from other global central labs facilities in PPD Clicks, a secure website the company launched earlier in 2008.
The new lab is expected to strengthen PPD’s presence in Singapore, where for a number of years the company has provided a range of clinical development services including clinical trial management and monitoring, patient recruitment, site identification and regulatory affairs.
Agostino Fede, senior vice president of PPD, said: “Southeast Asia is an attractive region for conducting clinical trials, and Singapore is an important biopharmaceutical hub. Establishing a direct lab presence in Singapore will enhance our abilities to reduce turnaround time and deliver high quality specimens and laboratory results at better logistics costs for our clients.”